Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Betathine trial progressing well

May 24, 1999

News from ASCO: phase I trial of PNU-214565 dose escalation tied to baseline anti-SEA antibodies

May 21, 1999

Avax enters research agreement with University of Tokyo for breast cancer vaccine

May 21, 1999

AltaRex grants Purdue Pharma an option to license two AIT products

May 18, 1999

Onyvax licenses anticancer vaccine from CRCT

May 17, 1999

Ligand confirms that ECOG has initiated multicenter phase II study of Ontak for NHL

May 13, 1999

Promising phase I/II results for Leuvectin in prostate cancer presented at AUA meeting

May 5, 1999

Cantab in-licenses Novasomes adjuvant for use in TA-CIN vaccine; clinical testing in sight

April 26, 1999

Promising results reported at AACR meeting from M-Vax trial in advanced melanoma

April 21, 1999

Recombinant immunotoxin for hematological malignancies from NCI evaluated in phase I

April 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...